Labiotech.eu

Inside Labiotech 14 Feb 2019

Say Hello to The Brand-New Labiotech.eu, Our Biggest Product Redesign Since We Launched 💥

You might have noticed that something changed on our site today. Indeed, we’re very proud to launch our brand-new website, which we started from scratch on a blank piece of paper. We are further improving your user experience and the page performance, and we’ll have the possibility of adding more crazy features in the coming […]

February 14, 2019 - 4 minutesmins - By Philip Hemme

Interview 13 Feb 2019

Embracing Risk to Succeed in Biotech

Biotech can be a very risky business, but embracing the risk can be the key to success. At our last Labiotech Refresh in Heidelberg, we got to talk to Friedrich von Bohlen, scientist, entrepreneur and investor, about how he approaches risk and what he thinks about the future of biotech. Friedrich von Bohlen is the […]

February 13, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

glanbia ireland agrichemwhey dairy whey biorefinery 1

News and Trends 13 Feb 2019

First Plant in the Works to Turn Dairy Byproducts Into Plastics

The company Glanbia Ireland is planning to construct the first industrial biorefinery that transforms dairy waste products into lactic acid, a building block for biodegradable plastics. Supported by the EU project AgriChemWhey, Glanbia Ireland plans to scale up biorefinery technology that ferments dairy waste, like whey permeate, into lactic acid, using a group of bacteria […]

February 13, 2019 - 2 minutesmins - By Jonathan Smith

More News! 12 Feb 2019

First Industrial Plant to Turn Waste into Chemicals Will Open in France

The French company Afyren has received up to €60M to commercialize a technology that uses bacteria to produce industrial chemicals from recycled plant waste instead of fossil fuels. Afyren takes sugars from the waste byproducts of agriculture, food, and other industries, and ferments the sugars into industrial chemicals using bacteria. With this new funding, the […]

February 12, 2019 - 2 minutesmins - By Jonathan Smith

Inside Labiotech 12 Feb 2019

Why We Love Being the Main Media Partner of BIO-Europe

We love partnering with cool people and companies—in return, we get to be in the middle of the action, get our name out there, and bring you all the very best of the events we attend. One of our favorite partnerships is with EBD Group, which are running BIO-Europe. Here’s why we love partnering with […]

February 12, 2019 - 2 minutesmins - By Philip Hemme

grey wolf therapeutics cancer immunotherapies

News and Trends 11 Feb 2019

Series A to Fund Therapy That Exposes Cancer to Immune System

The UK biotech Grey Wolf Therapeutics has raised €11.4M (£10M) to fuel the development of a cancer therapy that flushes tumor cells out of hiding from the immune system. Many approved cancer immunotherapies, such as CAR-T cell therapy and checkpoint inhibitors, have made a big difference for many people with cancer. However, a common problem with […]

February 11, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for the rights to the technology’s intellectual property, how difficult is it for third parties to access this coveted technology? The CRISPR patent dispute is quite unique. While universities usually work together to disseminate innovation and knowledge, in the CRISPR case […]

February 11, 2019 - 5 minutesmins - By Timothé Cynober

equi nom israel genomics selective breeding legume

Startup Scout 8 Feb 2019

This Biotech Uses Genomics to Breed Super Peas

This week’s biotech, Equi-Nom, is based in Israel. With its genomics and computer modeling technology, the company helps plant producers to breed pulses that contain more protein without any genetic modification. Mission: To boost the protein content in pulses, such as peas, without editing their DNA. Instead, the company speeds up traditional breeding by […]

February 8, 2019 - 4 minutesmins - By Jonathan Smith

More News! 8 Feb 2019

Swiss Firm Launches Cancer Test That Gives Results in Minutes

Lunaphore Technologies has launched a device for automated testing of cancer tissue samples that gives results in under 30 minutes. Lunaphore has developed a piece of next-generation equipment to perform immunohistochemistry (IHC) tests, a common technique used to find specific cancer biomarkers in tissue samples from cancer patients after a biopsy. The equipment, called LabSat, will […]

February 8, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

CRISPR Cas9 bacteriophage anti CRISPR gut microbiome 1

News and Trends 8 Feb 2019

Anti-CRISPR Proteins Could Improve Gene Editing Precision

A research group in Denmark has found proteins in gut and soil microbes that can inhibit the action of CRISPR-Cas9 gene editing, a finding that could help to control the technology with more precision and less risk. Bacteria and viruses have fought an evolutionary arms race for millions of years. Bacteria evolved CRISPR systems to […]

February 8, 2019 - 3 minutesmins - By Jonathan Smith

More News! 6 Feb 2019

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

Orexia and Inexia, two new virtual companies spun out of Sosei Heptares, will develop drugs for neurological diseases such as narcolepsy with funding from Medicxi Ventures. The companies will develop drugs that activate two molecules called OX1 and OX2. These molecules act as receptors of orexin, a protein that regulates arousal, wakefulness and sleep. The […]

February 6, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

breast cancer metformin klefstrom checkpoint inhibitor thumbnail

News and Trends 6 Feb 2019

Combo of Immunotherapy and Diabetes Drug Could Beat Breast Cancer

A Finnish research group has combined two cancer drugs with the diabetes drug metformin, making mice with breast cancer survive for longer than when given the treatments individually. The combination therapy included metformin, which can inhibit tumor growth; the cancer drug venetoclax, which causes cancer cells to commit suicide; and a checkpoint inhibitor antibody, which […]

February 6, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Say Hello to The Brand-New Labiotech.eu, Our Biggest Product Redesign Since We Launched 💥

Embracing Risk to Succeed in Biotech

First Plant in the Works to Turn Dairy Byproducts Into Plastics

First Industrial Plant to Turn Waste into Chemicals Will Open in France

Why We Love Being the Main Media Partner of BIO-Europe

Series A to Fund Therapy That Exposes Cancer to Immune System

CRISPR: One Patent to Rule Them All

This Biotech Uses Genomics to Breed Super Peas

Swiss Firm Launches Cancer Test That Gives Results in Minutes

Anti-CRISPR Proteins Could Improve Gene Editing Precision

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

Combo of Immunotherapy and Diabetes Drug Could Beat Breast Cancer

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!